CERo Therapeutics Holdings Inc (NASDAQ:CERO) concluded the trading at $1.11 on current market day with a rise of 38.85% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.80 and 5Y monthly beta was reading 0.729 with its price kept floating in the range of $0.88 and $1.42 on the day. Considering stock’s 52-week price range provides that CERO hit a high price of $171.00 and saw its price falling to a low level of $0.53 during that period. Over a period of past 1-month, stock came adding 25.28% in its value.
With its current market valuation of $5.97 million, CERo Therapeutics Holdings Inc is set to declare its quarterly results in May. Analysts are in estimates of -5.96 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -7.29 for current year with estimates of that growing to -0.86 in next year.
In contrast, when we review CERO stock’s current outlook then short term indicators are assigning it an average of 50% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.
Digging deeper we become aware of the PEG ratio of the CERO stock which is currently positioned at 0. It further provides that stock’s current price level is 52.00% away from its 20-day simple moving average and is -1.84% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 60.91 while volatility remained at 22.92% over the past week which changes to 17.04% when measuring it over the past month. Beta is valued at 0.62, while measure of average true range or ATR is currently at 0.16.
The percentage of outstanding shares held by the insiders is 31.95% while it is 4.80% for the institutional holders. The figures also indicate that as of 2025-03-31, number of stock’s short shares was 0.34 million which implies a short ratio of 0.36. This shows up a 1490.00 of Short Interest in company’s outstanding shares on the day. In March the standing of shares short improved as it was 0.29 million in the previous month. Subtraction of -81.50% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
